Abcellera Biologics

-$0.25 (-1.61%) Today

$0.00 (0.00%) As of 9:13 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ABCL and other ETFs, options, and stocks.

About ABCL

AbCellera Biologics, Inc. engages in the development of therapeutic antibodies. It offers antibody discovery platform that searches, decodes and analyzes natural immune systems to find antibodies that can be developed to prevent and treat disease.

CEO

Carl Lars G. Hansen

Employees

206

Headquarters

Vancouver, British Columbia

Founded

2012

ABCL Key Statistics

Market Cap

4.26B

Price-Earnings Ratio

18.43

Dividend Yield

—

Average Volume

1.61M

High Today

$15.75

Low Today

$15.17

Open Price

$15.40

Volume

1.07M

52 Week High

$71.91

52 Week Low

$14.51

ABCL News

Simply Wall StOct 16

Could The AbCellera Biologics Inc. Ownership Structure Tell Us Something Useful?

The big shareholder groups in AbCellera Biologics Inc. (NASDAQ:ABCL) have power over the company. Insiders often own a large chunk of younger, smaller, companie

ABCL Earnings

-$0.03

$0.18

$0.40

$0.61

Q4 FY20

Q1 FY21

Q2 FY21

Q3 FY21

Estimated

-$0.03 per share

Actual

Available Nov 9, After Hours

Why Robinhood?

AbCellera Biologics, Inc. engages in the development of therapeutic antibodies. It offers antibody discovery platform that searches, decodes and analyzes natural immune systems to find antibodies that can be developed to prevent and treat disease. View more

Could The AbCellera Biologics Inc. Ownership Structure Tell Us Something Useful?

AbCellera Biologics, Inc. engages in the development of therapeutic antibodies. It offers antibody discovery platform that searches, decodes and analyzes natural immune systems to find antibodies that can be developed to prevent and treat disease.